Andrew Feinberg

President & CEO BostonGene

Last Reviewed: September 26, 2026

Executive Summary

Andrew Feinberg runs two companies in unrelated industries. He is co-founder, President and CEO of BostonGene, a Waltham, Massachusetts company founded in 2015 that combines multi-omics data with AI to guide cancer treatment and drug development. He is also Chairman and CEO of Netcracker Technology, the telecommunications software company that NEC Corporation owns outright. In May 2026 NEC completed its acquisition of CSG Systems International and appointed him Chairman and CEO of the combined Netcracker and CSG business. Netcracker billed him as a main-stage keynote speaker at MWC Barcelona 2026, talking about how to govern AI at scale and drawing on both companies.

Career Highlights

• Co-founder, President and CEO of BostonGene, which applies AI to multi-omics data for cancer care and drug development.
• Chairman and CEO of Netcracker Technology, a wholly owned subsidiary of NEC Corporation serving communications service providers.
• Appointed Chairman and CEO of the combined organization when NEC completed its acquisition of CSG Systems International on May 14, 2026, with Netcracker taking responsibility for CSG’s operations and integration.
• Listed as a main-stage keynote speaker at MWC Barcelona on March 3, 2026, on turning AI into lasting value through strong governance.

Professional Journey

Netcracker, which Feinberg co-founded, sells billing, operations and customer management software to telecom operators. According to the company, it grew independently for 15 years before becoming a wholly owned subsidiary of NEC Corporation in 2008. NEC has since moved all of its telecom software and services assets into Netcracker. Feinberg is its Chairman and CEO. His MWC biography credits him with sustained double-digit growth and with making Netcracker a leader in digital transformation for communications service providers.

In 2015 he co-founded BostonGene, a company with a very different focus. BostonGene decodes the molecular profiles of cancer patients with an AI-powered multi-omics platform, looking for the drivers of disease and for new drug targets, and it works with cancer centers and pharmaceutical companies. As President and CEO he has spoken for the company on its hiring, including the appointment of Ferran Prat as Chief Commercial Officer in April 2025.

His Netcracker role grew in 2026. On May 14, 2026, NEC and Netcracker announced that NEC had completed its acquisition of CSG Systems International, a U.S. provider of software for telecom, broadband and digital service providers. Netcracker took over CSG’s operations and integration, and Feinberg was appointed Chairman and CEO of the combined organization. He said the deal created “one of the industry’s most complete digital platforms, connecting customer engagement, monetization and operations in a single environment.” Earlier that year Netcracker announced that he would give a keynote on the MWC Barcelona main stage on March 3, 2026, about how scaling AI responsibly can benefit both telecom and the life sciences; MWC’s agenda lists the session. Netcracker’s release of September 22, 2026 still gives both of his titles, Chairman and CEO of Netcracker and President and CEO of BostonGene.

Education

No education record was found in a first-party or filed source. Aggregator claims are noted in the verification notes and are not recorded.